Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R M Stone

Leukemia

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Leukemia|March 21, 2003
Induction and postremission therapy: new agentsR M Stone
Leukemia|August 13, 2009
Iron chelation therapy in myelodysplastic syndrome - Cui bono?A Tefferi, R M Stone
Leukemia|March 1, 1993
All-trans retinoic acid induces monocyte growth factor receptor (c-fms) gene expression in HL-60 leukemia cellsH C Hsu, K Yang, S Kharbanda, et al.
Leukemia|December 1, 1990
A phase I study of intermittent continuous infusion high dose cytosine arabinoside for acute leukemiaR M Stone, D R Spriggs, R K Dhawan, et al.
Leukemia|March 29, 2013
SYK regulates mTOR signaling in AMLJ Carnevale, L Ross, A Puissant, et al.
Leukemia|February 6, 2004
Decision-making and quality of life in older adults with acute myeloid leukemia or advanced myelodysplastic syndromeM A Sekeres, R M Stone, D Zahrieh, et al.
Leukemia|October 22, 2004
KIAA1509 is a novel PDGFRB fusion partner in imatinib-responsive myeloproliferative disease associated with a t(5;14)(q33;q32)R L Levine, M Wadleigh, D W Sternberg, et al.
Leukemia|May 24, 2016
KPT-8602, a second-generation inhibitor of XPO1-mediated nuclear export, is well tolerated and highly active against AML blasts and leukemia-initiating cellsJ Etchin, A Berezovskaya, A S Conway, et al.
Leukemia|February 16, 2011
Escalation of daunorubicin and addition of etoposide in the ADE regimen in acute myeloid leukemia patients aged 60 years and older: Cancer and Leukemia Group B Study 9720M R Baer, S L George, B L Sanford, et al.
Leukemia|May 26, 2012
Phase IB study of the FLT3 kinase inhibitor midostaurin with chemotherapy in younger newly diagnosed adult patients with acute myeloid leukemiaR M Stone, T Fischer, R Paquette, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Leukemia|March 21, 2003
Induction and postremission therapy: new agentsR M Stone
Leukemia|August 13, 2009
Iron chelation therapy in myelodysplastic syndrome - Cui bono?A Tefferi, R M Stone
Leukemia|March 1, 1993
All-trans retinoic acid induces monocyte growth factor receptor (c-fms) gene expression in HL-60 leukemia cellsH C Hsu, K Yang, S Kharbanda, et al.
Leukemia|December 1, 1990
A phase I study of intermittent continuous infusion high dose cytosine arabinoside for acute leukemiaR M Stone, D R Spriggs, R K Dhawan, et al.
Leukemia|March 29, 2013
SYK regulates mTOR signaling in AMLJ Carnevale, L Ross, A Puissant, et al.
Leukemia|February 6, 2004
Decision-making and quality of life in older adults with acute myeloid leukemia or advanced myelodysplastic syndromeM A Sekeres, R M Stone, D Zahrieh, et al.
Leukemia|October 22, 2004
KIAA1509 is a novel PDGFRB fusion partner in imatinib-responsive myeloproliferative disease associated with a t(5;14)(q33;q32)R L Levine, M Wadleigh, D W Sternberg, et al.
Leukemia|May 24, 2016
KPT-8602, a second-generation inhibitor of XPO1-mediated nuclear export, is well tolerated and highly active against AML blasts and leukemia-initiating cellsJ Etchin, A Berezovskaya, A S Conway, et al.
Leukemia|February 16, 2011
Escalation of daunorubicin and addition of etoposide in the ADE regimen in acute myeloid leukemia patients aged 60 years and older: Cancer and Leukemia Group B Study 9720M R Baer, S L George, B L Sanford, et al.
Leukemia|May 26, 2012
Phase IB study of the FLT3 kinase inhibitor midostaurin with chemotherapy in younger newly diagnosed adult patients with acute myeloid leukemiaR M Stone, T Fischer, R Paquette, et al.
Pageof 3